XT
KYNB

XTX Topco’s Kyntra Bio KYNB Stock Holding History

XTX Topco’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,445
Closed -$26.7K – 2611
2025
Q1 		$26.7K Sell
3,445
-396
-10% -$4.75K ﹤0.01% 2095
2024
Q4 		$50.8K Buy
3,841
+3,108
+424% +$28.9K ﹤0.01% 1890
2024
Q3 		$7.32K Sell
733
-18,296
-96% -$276K ﹤0.01% 1954
2024
Q2 		$424K Buy
+19,029
New +$588K 0.04% 742
2024
Q1 		– Sell
-2,451
Closed -$54.3K – 1984
2023
Q4 		$54.3K Sell
2,451
-4,529
-65% -$68.3K 0.01% 1220
2023
Q3 		$151K Buy
6,980
+6,391
+1,085% +$251K 0.03% 1104
2023
Q2 		$39.8K Buy
+589
New +$244K 0.01% 1265

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

XTX Topco's KYNB Position: Q2 2025 in Review

XTX Topco sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 3,445 shares — an estimated $26.7K sold.

XTX Topco first reported a position in KYNB in Q2 2023 and held it in 7 quarters. The position peaked at $424K in Q2 2024. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • XTX Topco reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 3,445 Kyntra Bio shares in Q2 2025, an estimated $26.7K.
  • XTX Topco first reported a position in Kyntra Bio in Q2 2023 and held it in 7 quarters.
  • XTX Topco's Kyntra Bio position peaked at $424K in Q2 2024.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.